[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[S. 107 Introduced in Senate (IS)]

103d CONGRESS
  1st Session
                                 S. 107

 To mandate a study of the effectiveness of the National Drug Strategy 
       and to provide for an accounting of funds devoted to its 
                implementation, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

             January 21 (legislative day, January 5), 1993

  Mr. Moynihan (for himself and Mr. Chafee) introduced the following 
 bill; which was read twice and referred to the Committee on Labor and 
                            Human Resources

_______________________________________________________________________

                                 A BILL


 
 To mandate a study of the effectiveness of the National Drug Strategy 
       and to provide for an accounting of funds devoted to its 
                implementation, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. FINDINGS.

    The Congress finds that--
            (1) there is great disagreement concerning the causes of 
        the problem of epidemic drug addiction in the United States and 
        about the most effective way to reduce it;
            (2) one of the factors which most inhibits an effective 
        response to the problem of epidemic drug addiction in the 
        United States is the lack of accurate information concerning 
        both the problem and the specific effectiveness of each 
        individual element of the Nation's antidrug effort;
            (3) evaluating the effectiveness of the individual elements 
        of the Federal program to reduce epidemic drug abuse requires 
        accurately establishing cause and effect relationship 
        concerning drug addiction;
            (4) the United States has promulgated a National Drug 
        Strategy pursuant to the requirements of the 1988 Anti-Drug 
        Abuse Act and will devote many billions of dollars to antidrug 
        programs for many years to come; and
            (5) it is in the interests of the Nation that these funds 
        be spent as effectively as possible and that a permanent 
        mechanism exist to audit their expenditure.

SEC. 2. PURPOSES.

    The purposes of this Act are to--
            (1) require a study of the effectiveness of federally 
        funded antidrug programs; and
            (2) create a permanent auditing mechanism for federally 
        funded antidrug programs.

SEC. 3. STUDY OF ANTI-DRUG PROGRAMS.

    (a) In General.--The Secretary of Health and Human Services 
(referred to in this Act as the ``Secretary'') shall enter into 
appropriate arrangements with the National Academy of Sciences to 
conduct a comprehensive study and investigation of the effectiveness in 
reducing drug addiction of the various components of the Federal 
antidrug program, including--
            (1) crop eradication;
            (2) crop substitution;
            (3) support for foreign law enforcement;
            (4) interdiction, including a separate analysis of the 
        effectiveness of the military services in the interdiction 
        effort;
            (5) education;
            (6) treatment;
            (7) support for local law enforcement;
            (8) criminal justice system reforms; and
            (9) research, including a separate analysis of 
        effectiveness of pharmocological research and research into 
        other types of medical treatments for drug addiction.
    (b) Methodology.--The study described in subsection (a) shall to 
the maximum extent possible--
            (1) study control for the effects of broad societal changes 
        unrelated to specific antidrug initiatives, such as changing 
        demographic patterns;
            (2) separate the effects of such component of the Federal 
        antidrug program from the effects of other antidrug 
        initiatives;
            (3) consider the extent to which the expenditure of Federal 
        funds on job training, education, and other health, education, 
        and welfare programs contribute to reducing epidemic drug 
        addiction;
            (4) study the cost-effectiveness of each component of the 
        Federal antidrug program, as well as the programs described in 
        paragraph (3); and
            (5) take into account the social and demographic factors 
        which influence rates and forms of epidemic drug addiction and 
        provide, where possible, information on the effectiveness of 
        the various components of the Federal antidrug program on 
        various demographic subgroups within the population.
    (c) Reporting.--In conducting the study described in subsection 
(a), the National Academy of Sciences shall provide to the Secretary 
and the Congress--
            (1) not later than 6 months after the date of enactment of 
        this Act a detailed written description of the manner in which 
        the study will be conducted, including a specific set of goals 
        for the study;
            (2) not later than 18 months after the date of enactment of 
        this Act the preliminary results of the study; and
            (3) not later than 2 years after the date of enactment of 
        this Act the final results of the study.
    (d) Update of Study.--The Secretary shall enter into appropriate 
arrangements with the National Academy of Sciences to update the 
results of the study described in subsection (a) every 2 years 
following the initial report.
    (e) Assistance From Federal Agencies.--Agencies of the Federal 
Government shall provide to the National Academy of Sciences such 
information as it may reasonably request for the purpose of conducting 
the study described in subsection (a).

SEC. 4. AUDIT BY THE GOVERNMENT ACCOUNTING OFFICE.

    (a) In General.--The Government Accounting Office shall provide to 
the Congress on an annual basis an audit report concerning the 
management and expenditures of the component parts of the Federal 
antidrug program.
    (b) Separate Components.--The report described in (a) shall contain 
a separate section on each of the component parts of the Federal 
antidrug program.
    (c) Access to Records.--In order to carry out the purposes of this 
section, the Comptroller General shall have such access to records, 
files, personnel, and facilities of the Federal agencies involved in 
the Federal antidrug program, including the military and intelligence 
services, as the Comptroller General considers necessary.

                                 <all>